Related Experiment Videos
Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled
M C Chui1, D E Newby, M Panarelli
1Department of Cardiology, Royal Infirmary, Edinburgh, Scotland, UK.
Insights
High cholesterol (hypercholesterolemia) is linked to calcific aortic stenosis. This finding suggests cholesterol management may play a role in preventing or slowing this heart valve disease.
Area of Science:
- Cardiology
- Vascular Biology
- Biochemistry
Background:
- Calcific aortic stenosis (CAS) shares potential etiological factors with atherosclerosis.
- Understanding these shared factors is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the association between hypercholesterolemia and calcific aortic valve stenosis.
- To determine if elevated cholesterol levels are a risk factor for CAS.
Main Methods:
- Retrospective case-control study design.
- Inclusion of consecutive patients undergoing aortic or mitral valve replacement.
- Collection of preoperative data including demographics, comorbidities, and serum lipid profiles.
Main Results:
- Patients with calcific aortic stenosis exhibited significantly higher serum total cholesterol levels compared to controls (p < 0.001).
- This association remained significant after adjusting for gender, body mass index, and excluding patients with coronary artery disease.
- The link between elevated cholesterol and CAS was particularly pronounced in individuals with tricuspid aortic valves.
Conclusions:
- Hypercholesterolemia is significantly associated with calcific aortic stenosis.
- Elevated cholesterol may contribute to the pathogenesis and progression of CAS.
- Further research, including randomized controlled trials of cholesterol-lowering therapy, is warranted for CAS patients.
Background:
Calcific aortic stenosis may have common etiological factors with atherosclerosis.
Hypothesis:
In this retrospective, case-control study, we aimed to determine whether there is an association between hypercholesterolemia and calcific aortic valve stenosis.
Methods:
Consecutive patients undergoing single aortic or mitral valve replacement in a regional cardiothoracic surgical center were reviewed and preoperative patient characteristics were recorded: demographics, comorbidity (including coronary artery disease and associated risk factors), serum total cholesterol, lipid-lowering therapy, and serum creatinine.
Results:
Serum total cholesterol concentrations were significantly higher in patients with calcific aortic stenosis than in controls (6.2+/-1.1 vs. 5.3+/-1.1 mmol/l; p < 0.001). The significant difference in serum cholesterol concentrations remained following correction for gender and body mass index (p = 0.02) and when patients with coronary artery disease were excluded (6.3+/-1.1 vs. 5.3+/-1.4 mmol/l; p<0.001). Subgroup analysis demonstrated that the association between elevated serum cholesterol concentrations and calcific aortic stenosis was particularly strong in patients with tricuspid aortic valves (6.4+/-1.2 vs. 5.3+/-1.1 mmol/l; p < 0.001) compared with those with bicuspid valves (5.9+/-1.1 vs. 5.3+/-1.1 mmol/l; p = 0.06).
Conclusions:
We conclude that hypercholesterolemia is associated with calcific aortic stenosis and may be implicated in its pathogenesis and progression. We believe that there is now a need for a randomized, controlled trial of cholesterol-lowering therapy in patients with calcific aortic stenosis.